Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ribonuclease, Pancreatic | 7 | 2022 | 112 | 0.950 |
Why?
|
Heparin | 5 | 2023 | 1636 | 0.580 |
Why?
|
Antithrombins | 2 | 2023 | 294 | 0.350 |
Why?
|
Isoquinolines | 2 | 2021 | 349 | 0.330 |
Why?
|
Lung | 9 | 2023 | 10076 | 0.320 |
Why?
|
Vascular Endothelial Growth Factor A | 6 | 2022 | 3511 | 0.290 |
Why?
|
Glycine | 2 | 2021 | 670 | 0.280 |
Why?
|
Bystander Effect | 1 | 2006 | 89 | 0.260 |
Why?
|
Pneumonectomy | 6 | 2023 | 1147 | 0.230 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2020 | 547 | 0.220 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2011 | 1481 | 0.220 |
Why?
|
Pipecolic Acids | 1 | 2023 | 77 | 0.220 |
Why?
|
Serpins | 2 | 2021 | 246 | 0.210 |
Why?
|
Arachidonic Acid | 1 | 2024 | 430 | 0.210 |
Why?
|
Iodine Radioisotopes | 1 | 2006 | 1029 | 0.200 |
Why?
|
Nerve Growth Factors | 2 | 2021 | 564 | 0.190 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2024 | 314 | 0.190 |
Why?
|
Eye Proteins | 2 | 2021 | 628 | 0.180 |
Why?
|
Arginine | 1 | 2023 | 931 | 0.170 |
Why?
|
Parenteral Nutrition | 1 | 2024 | 663 | 0.170 |
Why?
|
Mice, Inbred C57BL | 9 | 2024 | 22361 | 0.160 |
Why?
|
Pulmonary Alveoli | 2 | 2020 | 665 | 0.160 |
Why?
|
Cell Proliferation | 6 | 2022 | 10455 | 0.150 |
Why?
|
RNA, Ribosomal | 2 | 2009 | 227 | 0.150 |
Why?
|
Docosahexaenoic Acids | 1 | 2024 | 914 | 0.140 |
Why?
|
Endothelial Cells | 5 | 2022 | 3582 | 0.140 |
Why?
|
Nerve Tissue Proteins | 2 | 2022 | 4401 | 0.140 |
Why?
|
Neovascularization, Physiologic | 4 | 2018 | 1368 | 0.120 |
Why?
|
Infant, Premature | 1 | 2024 | 2125 | 0.120 |
Why?
|
Ribonucleases | 2 | 2012 | 266 | 0.110 |
Why?
|
Sulfonamides | 1 | 2023 | 1982 | 0.110 |
Why?
|
Mice | 17 | 2024 | 81912 | 0.100 |
Why?
|
Carcinoma, Embryonal | 1 | 2010 | 36 | 0.090 |
Why?
|
Culture Media, Serum-Free | 1 | 2010 | 147 | 0.090 |
Why?
|
Neurogenesis | 2 | 2017 | 863 | 0.090 |
Why?
|
Hirudins | 2 | 2023 | 179 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3738 | 0.090 |
Why?
|
Epithelial Cells | 1 | 2021 | 3698 | 0.080 |
Why?
|
Glioblastoma | 2 | 2022 | 3461 | 0.080 |
Why?
|
Oncogene Protein v-akt | 1 | 2009 | 130 | 0.080 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2009 | 80 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7578 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2006 | 6360 | 0.080 |
Why?
|
Animals | 18 | 2024 | 168965 | 0.080 |
Why?
|
Respiratory Function Tests | 2 | 2020 | 1695 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2023 | 6507 | 0.060 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2006 | 876 | 0.060 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2006 | 393 | 0.060 |
Why?
|
Organ Size | 2 | 2020 | 2264 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9464 | 0.060 |
Why?
|
Soybean Oil | 1 | 2024 | 139 | 0.050 |
Why?
|
Th2 Cells | 2 | 2006 | 1077 | 0.050 |
Why?
|
Thrombin | 1 | 2023 | 600 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2003 | 897 | 0.050 |
Why?
|
Lead | 1 | 2006 | 882 | 0.040 |
Why?
|
Fish Oils | 1 | 2024 | 483 | 0.040 |
Why?
|
Compliance | 1 | 2020 | 100 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2022 | 344 | 0.040 |
Why?
|
Picolinic Acids | 1 | 2020 | 48 | 0.040 |
Why?
|
Total Lung Capacity | 1 | 2020 | 148 | 0.040 |
Why?
|
Hematocrit | 1 | 2021 | 622 | 0.040 |
Why?
|
Mice, Nude | 1 | 2006 | 3618 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2006 | 2093 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18330 | 0.040 |
Why?
|
Peptide Fragments | 2 | 2023 | 5141 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2018 | 150 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2006 | 3154 | 0.040 |
Why?
|
Fatty Liver | 1 | 2024 | 811 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2009 | 7611 | 0.040 |
Why?
|
Half-Life | 1 | 2018 | 648 | 0.040 |
Why?
|
Radiation Dosage | 1 | 2006 | 1965 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 17097 | 0.040 |
Why?
|
Parkinson Disease | 1 | 2011 | 2886 | 0.040 |
Why?
|
Anticoagulants | 2 | 2023 | 4854 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10748 | 0.040 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 363 | 0.030 |
Why?
|
Organogenesis | 1 | 2018 | 214 | 0.030 |
Why?
|
Genetic Variation | 1 | 2011 | 6611 | 0.030 |
Why?
|
Microcirculation | 1 | 2021 | 1282 | 0.030 |
Why?
|
Drug Design | 1 | 2021 | 1045 | 0.030 |
Why?
|
Hyperoxia | 1 | 2018 | 259 | 0.030 |
Why?
|
Male | 12 | 2024 | 364203 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 559 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 2018 | 697 | 0.030 |
Why?
|
Apoptosis | 1 | 2010 | 9513 | 0.030 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2018 | 329 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2079 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2017 | 2012 | 0.030 |
Why?
|
Exercise Test | 1 | 2021 | 2188 | 0.030 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 686 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1144 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8048 | 0.030 |
Why?
|
Interleukin-4 | 2 | 2006 | 1156 | 0.020 |
Why?
|
Humans | 11 | 2024 | 767040 | 0.020 |
Why?
|
Cytochromes c | 1 | 2010 | 173 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18063 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2021 | 14476 | 0.020 |
Why?
|
Neomycin | 1 | 2009 | 94 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8310 | 0.020 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2009 | 187 | 0.020 |
Why?
|
Dactinomycin | 1 | 2009 | 304 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2012 | 1892 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5794 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5750 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2827 | 0.020 |
Why?
|
Caspases | 1 | 2010 | 881 | 0.020 |
Why?
|
Ferrous Compounds | 1 | 2006 | 40 | 0.020 |
Why?
|
STAT4 Transcription Factor | 1 | 2006 | 94 | 0.020 |
Why?
|
Zinc Compounds | 1 | 2006 | 36 | 0.020 |
Why?
|
Signal Transduction | 2 | 2021 | 23621 | 0.020 |
Why?
|
STAT6 Transcription Factor | 1 | 2006 | 196 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2011 | 1733 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2007 | 432 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 11097 | 0.020 |
Why?
|
Cell Line | 2 | 2012 | 15567 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2003 | 11657 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 11923 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 678 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2017 | 3408 | 0.020 |
Why?
|
Ovalbumin | 1 | 2006 | 677 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 2 | 2010 | 4522 | 0.010 |
Why?
|
Europe | 1 | 2011 | 3432 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2006 | 577 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26396 | 0.010 |
Why?
|
Chlorides | 1 | 2006 | 666 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1405 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2003 | 69 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6067 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4572 | 0.010 |
Why?
|
Mutation | 1 | 2007 | 30211 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1751 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 6106 | 0.010 |
Why?
|
Motor Neurons | 1 | 2007 | 869 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 4247 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 2493 | 0.010 |
Why?
|
Th1 Cells | 1 | 2006 | 1040 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12414 | 0.010 |
Why?
|
NFATC Transcription Factors | 1 | 2003 | 393 | 0.010 |
Why?
|
Heterozygote | 1 | 2007 | 2794 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2006 | 1560 | 0.010 |
Why?
|
Spleen | 1 | 2006 | 2292 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2006 | 1319 | 0.010 |
Why?
|
Fetus | 1 | 2007 | 1878 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4143 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3427 | 0.010 |
Why?
|
Spinal Cord | 1 | 2007 | 1811 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2931 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2007 | 2875 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2007 | 2592 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6226 | 0.010 |
Why?
|
Databases, Factual | 1 | 2011 | 8068 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2006 | 3076 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8628 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9551 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2006 | 12793 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21178 | 0.010 |
Why?
|
Female | 3 | 2017 | 396660 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9612 | 0.000 |
Why?
|
Time Factors | 1 | 2006 | 40154 | 0.000 |
Why?
|
Cohort Studies | 1 | 2007 | 41718 | 0.000 |
Why?
|
Transcription Factors | 1 | 2003 | 12158 | 0.000 |
Why?
|
United States | 1 | 2011 | 72971 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2007 | 59548 | 0.000 |
Why?
|
Middle Aged | 1 | 2007 | 223233 | 0.000 |
Why?
|
Adult | 1 | 2007 | 223317 | 0.000 |
Why?
|
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_